Ocular Surgery News / Aganirsen eye drops demonstrated significant benefits among patients with keratitis
Xconomy San Diego 2014 / Antisense and disruptive technologies for drug discovery…..
Schweiz am Sonntag / Kleinfirma greift…… (DE / ENG)
The Pink Sheet Daily / Gene Signal Novel Corneal Neovascularisation product still on track…..
Google Alerts / Gene Signal on Google Alerts
FierceBiotech / PhIII eye drug failure? Not at all, says an optimistic Gene Signal
BioWorld Today / Gene Signal International sees enough in aganirsen phase III data for follow-up trial
Le Temps / Après avoir présenté des résultats positifs dans le traitement du psoriasis….
L’AGEFI / Gene Signal a obtenu des résultats positifs de l’étude phase III…
Reuters / Gene Signal in talks for a partner for eye disease drug
AWP Newswire / Résultats positifs avec gouttes de la molécule Aganirsen
Le Temps / Gene Signal demonstrates Aganirsen efficacy in dermatology
BioWorld Today / Aganirsen reduces the size of Psoriatic lesions....
Neue Zürcher Zeitung am Sonntag (NZZ) / Gene Signal – Gut unterwegs….
PME Magazine / Gene Signal lève des fonds
NATURE REVIEWS - DRUG DISCOVERY (VOL 12, MARCH) / Antisense approval provides boost to the field
L’AGEFI / La stratégie de niche sur le marché de l’angiogenèse
STARTUPTICKER.CH / Gene Signal announces completion of private funding round
TRANSKRIPT / Gene Signal
BIOPHARM INSIGHT / Gene Signal to start two Phase II ophthalmology trials by 4Q13
PHARMA TV / ERIC VIAUD, CEO talks to Pharma TV
LE TEMPS / Gene Signal
BIOTECH FINANCES / Levée vitaminée pour Gene Signal
BIOWORLD / Gene Signal Raises New Cash for Its Antisense Drug Trials
GENOME ENGINEERING / Antisense – Making sense at last?
DAILY RX / Eye Drops Successfully Treat AMD
MEDICAL NEWS TODAY / Topical Aganirsen Found To Be Active In Retinal Disease
CONTACTLENSES / New eyedrops "can prevent retinal disease"
BILAN / Menace lausannoise sur un blockbuster de roche et Novartis
LE TEMPS / Gene Signal s'attaque à des maladies ophthalmiques
MY PHARMA / Gene Signal : résultats positifs pour Aganirsen en usage topique sur des modèles de maladies rétiniennes
NEWS MEDICAL / Aganirsen demonstrates significant activity in two models of wet AMD, ischemic retinopathy
ESCRS EUROTIMES / Cornea Neovascularization Treatment
MED PAGE TODAY / Conditioning Cornea Improves Transplants
MD INDIA / Corneal Transplant Success Rate Can be Boosted by New Treatment Approach
PHYSORG.COM / Study finds new key to corneal transplant success
OPHTHALMOLOGY TIMES / Ribonucleotide aids post-graft healing
HEALIO / Antisense oligonucleotide drops may inhibit corneal neovascularization
DAILY MAIL / Your new cornea lasts longer
EYE DOC NEWS / Gene Signal Says GS-101 May Prevent Corneal Transplant Rejection
OPHTHALMOLOGY WEB / Gene Signal GS-101 data shows safe and effective inhibition of ophthalmic blood vessel growth
OPHTHALMOLOGY TIMES EUROPE / Graft rejection therapy enters Phase III
